These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Stem Cell Technology in Cardiac Regeneration: A Pluripotent Stem Cell Promise. Duelen R; Sampaolesi M EBioMedicine; 2017 Feb; 16():30-40. PubMed ID: 28169191 [TBL] [Abstract][Full Text] [Related]
32. Cell sources for cardiovascular tissue regeneration and engineering. Ugurlucan M; Yerebakan C; Furlani D; Ma N; Steinhoff G Thorac Cardiovasc Surg; 2009 Mar; 57(2):63-73. PubMed ID: 19241306 [TBL] [Abstract][Full Text] [Related]
33. Stem Cell Banking and Its Impact on Cardiac Regenerative Medicine. Bardelli S; Moccetti M Adv Exp Med Biol; 2016; 951():163-178. PubMed ID: 27837563 [TBL] [Abstract][Full Text] [Related]
34. Derivation of a cardiopoietic population from human mesenchymal stem cells yields cardiac progeny. Behfar A; Terzic A Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S78-82. PubMed ID: 16501637 [TBL] [Abstract][Full Text] [Related]
35. A chemical biology approach to myocardial regeneration. Willems E; Lanier M; Forte E; Lo F; Cashman J; Mercola M J Cardiovasc Transl Res; 2011 Jun; 4(3):340-50. PubMed ID: 21424858 [TBL] [Abstract][Full Text] [Related]
36. Stimulating Cardiogenesis as a Treatment for Heart Failure. Heallen TR; Kadow ZA; Kim JH; Wang J; Martin JF Circ Res; 2019 May; 124(11):1647-1657. PubMed ID: 31120819 [TBL] [Abstract][Full Text] [Related]
37. The Athena trials: Autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction. Henry TD; Pepine CJ; Lambert CR; Traverse JH; Schatz R; Costa M; Povsic TJ; David Anderson R; Willerson JT; Kesten S; Perin EC Catheter Cardiovasc Interv; 2017 Feb; 89(2):169-177. PubMed ID: 27148802 [TBL] [Abstract][Full Text] [Related]
38. Stem cell therapy: pieces of the puzzle. Schoenhard JA; Hatzopoulos AK J Cardiovasc Transl Res; 2010 Feb; 3(1):49-60. PubMed ID: 20119487 [TBL] [Abstract][Full Text] [Related]
39. Rationale and Design of a Clinical Trial to Evaluate the Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction: The Randomized Multicenter Double-Blind Controlled CAREMI Trial (Cardiac Stem Cells in Patients With Acute Myocardial Infarction). Sanz-Ruiz R; Casado Plasencia A; Borlado LR; Fernández-Santos ME; Al-Daccak R; Claus P; Palacios I; Sádaba R; Charron D; Bogaert J; Mulet M; Yotti R; Gilaberte I; Bernad A; Bermejo J; Janssens S; Fernández-Avilés F Circ Res; 2017 Jun; 121(1):71-80. PubMed ID: 28533209 [TBL] [Abstract][Full Text] [Related]
40. Maturation status of sarcomere structure and function in human iPSC-derived cardiac myocytes. Bedada FB; Wheelwright M; Metzger JM Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1829-38. PubMed ID: 26578113 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]